Citation: | Zhu Shufang, Mou Lisha. Application progress of mesenchymal stem cells in islet transplantation for type 1 diabetes mellitus[J]. ORGAN TRANSPLANTATION, 2024, 15(2): 214-219. doi: 10.3969/j.issn.1674-7445.2023194 |
[1] |
SUN H, SAEEDI P, KARURANGA S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183: 109119. DOI: 10.1016/j.diabres.2021.109119.
|
[2] |
SYED FZ. Type 1 diabetes mellitus[J]. Ann Intern Med, 2022, 175(3): ITC33-ITC48. DOI: 10.7326/AITC202203150.
|
[3] |
MARKMANN JF, RICKELS MR, EGGERMAN TL, et al. Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes[J]. Am J Transplant, 2021, 21(4): 1477-1492. DOI: 10.1111/ajt.16174.
|
[4] |
罗说明, 周智广. 1型糖尿病治疗新技术的现状与未来[J]. 中国医师杂志, 2023, 25(3): 321-324. DOI: 10.3760/cma.j.cn431274-20230215-00159.
LUO SM, ZHOU ZG. Current status and future of new technologies in the treatment of type 1 diabetes[J]. J Chin Physician, 2023, 25(3): 321-324. DOI: 10.3760/cma.j.cn431274-20230215-00159.
|
[5] |
MARFIL-GARZA BA, SHAPIRO AMJ, KIN T. Clinical islet transplantation: current progress and new frontiers[J]. J Hepatobiliary Pancreat Sci, 2021, 28(3): 243-254. DOI: 10.1002/jhbp.891.
|
[6] |
SONG N, SCHOLTEMEIJER M, SHAH K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential[J]. Trends Pharmacol Sci, 2020, 41(9): 653-664. DOI: 10.1016/j.tips.2020.06.009.
|
[7] |
张岐剑, 徐希明. 外胚层间充质干细胞的获取及应用[J]. 中国组织工程研究, 2023, 27(6): 928-934. DOI: 10.12307/j.issn.2095-4344.2023.6.xdkf202306020.
ZHANG QJ, XU XM. Acquisition and application of ectodermal mesenchymal stem cells[J]. Chin J Tissue Eng Res, 2023, 27(6): 928-934. DOI: 10.12307/j.issn.2095-4344.2023.6.xdkf202306020.
|
[8] |
LIN AD, TUNG MC, LU CH. The hernia sac-a suitable source for obtaining mesenchymal stem cells[J]. Surg Open Sci, 2021, 6: 40-44. DOI: 10.1016/j.sopen.2021.08.002.
|
[9] |
SHRESTHA M, NGUYEN TT, PARK J, et al. Immunomodulation effect of mesenchymal stem cells in islet transplantation[J]. Biomed Pharmacother, 2021, 142: 112042. DOI: 10.1016/j.biopha.2021.112042.
|
[10] |
MATSUZAKA Y, YASHIRO R. Therapeutic strategy of mesenchymal-stem-cell-derived extracellular vesicles as regenerative medicine[J]. Int J Mol Sci, 2022, 23(12): 6480. DOI: 10.3390/ijms23126480.
|
[11] |
THALAKIRIYAWA DS, JAYASOORIYA PR, DISSANAYAKA WL. Regenerative potential of mesenchymal stem cell-derived extracellular vesicles[J]. Curr Mol Med, 2022, 22(2): 98-119. DOI: 10.2174/1566524021666210211114453.
|
[12] |
LACHAUD CC, COBO-VUILLEUMIER N, FUENTE-MARTIN E, et al. Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses[J]. Front Cell Dev Biol, 2023, 11: 1089817. DOI: 10.3389/fcell.2023.1089817.
|
[13] |
YOUSEF HN, SAKR SM, SABRY SA. Mesenchymal stem cells ameliorate hyperglycemia in type I diabetic developing male rats[J]. Stem Cells Int, 2022: 7556278. DOI: 10.1155/2022/7556278.
|
[14] |
EL-SAWAH SG, RASHWAN HM, ALTHOBAITI F, et al. AD-MSCs and BM-MSCs ameliorating effects on the metabolic and hepato-renal abnormalities in type 1 diabetic rats[J]. Saudi J Biol Sci, 2022, 29(2): 1053-1060. DOI: 10.1016/j.sjbs.2021.09.067.
|
[15] |
HUBBER EL, RACKHAM CL, JONES PM. Protecting islet functional viability using mesenchymal stromal cells[J]. Stem Cells Transl Med, 2021, 10(5): 674-680. DOI: 10.1002/sctm.20-0466.
|
[16] |
RACKHAM CL, HUBBER EL, CZAJKA A, et al. Optimizing beta cell function through mesenchymal stromal cell-mediated mitochondria transfer[J]. Stem Cells, 2020, 38(4): 574-584. DOI: 10.1002/stem.3134.
|
[17] |
LI X, LANG H, LI B, et al. Change in viability and function of pancreatic islets after coculture with mesenchymal stromal cells: a systemic review and meta-analysis[J]. J Diabetes Res, 2020:5860417. DOI: 10.1155/2020/5860417.
|
[18] |
BRANDHORST H, BRANDHORST D, ABRAHAM A, et al. Proteomic profiling reveals the ambivalent character of the mesenchymal stem cell secretome: assessing the effect of preconditioned media on isolated human islets[J]. Cell Transplant, 2020, 29: 963689720952332. DOI: 10.1177/0963689720952332.
|
[19] |
KUPPAN P, SEEBERGER K, KELLY S, et al. Co-transplantation of human adipose-derived mesenchymal stem cells with neonatal porcine islets within a prevascularized subcutaneous space augments the xenograft function[J]. Xenotransplantation, 2020, 27(4): e12581. DOI: 10.1111/xen.12581.
|
[20] |
LI SW, CAI Y, MAO XL, et al. The immunomodulatory properties of mesenchymal stem cells play a critical role in inducing immune tolerance after liver transplantation[J]. Stem Cells Int, 2021: 6930263. DOI: 10.1155/2021/6930263.
|
[21] |
CORRADI-PERINI C, SANTOS TM, CAMARA NOS, et al. Co-transplantation of xenogeneic bone marrow-derived mesenchymal stem cells alleviates rejection of pancreatic islets in non-obese diabetic mice[J]. Transplant Proc, 2017, 49(4): 902-905. DOI: 10.1016/j.transproceed.2017.01.064.
|
[22] |
CHEN J, CHEN J, CHENG Y, et al. Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation[J]. Stem Cell Res Ther, 2020, 11(1): 97. DOI: 10.1186/s13287-020-01610-0.
|
[23] |
TAN Y, NIE W, CHEN C, et al. Mesenchymal stem cells alleviate hypoxia-induced oxidative stress and enhance the pro-survival pathways in porcine islets[J]. Exp Biol Med (Maywood), 2019, 244(9): 781-788. DOI: 10.1177/1535370219844472.
|
[24] |
XU Y, TAN M, MA X, et al. Human mesenchymal stem cells-derived conditioned medium inhibits hypoxia-induced death of neonatal porcine islets by inducing autophagy[J]. Xenotransplantation, 2020, 27(1): e12556. DOI: 10.1111/xen.12556.
|
[25] |
YU S, LU J. The potential of mesenchymal stem cells to induce immune tolerance to allogeneic transplants[J]. Transpl Immunol, 2023, 81: 101939. DOI: 10.1016/j.trim.2023.101939.
|
[26] |
YAN LL, YE LP, CHEN YH, et al. The influence of microenvironment on survival of intraportal transplanted islets[J]. Front Immunol, 2022, 13: 849580. DOI: 10.3389/fimmu.2022.849580.
|
[27] |
CAO XK, LI R, SUN W, et al. Co-combination of islets with bone marrow mesenchymal stem cells promotes angiogenesis[J]. Biomed Pharmacother, 2016, 78: 156-164. DOI: 10.1016/j.biopha.2016.01.007.
|
[28] |
LING Q, SHEN L, ZHANG W, et al. Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes[J]. Mol Med, 2022, 28(1): 18. DOI: 10.1186/s10020-022-00447-y.
|
[29] |
CONTRERAS-KALLENS P, TERRAZA C, OYARCE K, et al. Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance[J]. Ann N Y Acad Sci, 2018, 1417(1): 35-56. DOI: 10.1111/nyas.13364.
|
[30] |
ZHANG W, LING Q, WANG B, et al. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes[J]. Stem Cell Res Ther, 2022, 13(1): 406. DOI: 10.1186/s13287-022-02974-1.
|
[31] |
PIEKARSKA K, URBAN-WÓJCIUK Z, KURKOWIAK M, et al. Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity[J]. Nat Commun, 2022, 13(1): 856. DOI: 10.1038/s41467-022-28338-0.
|
[32] |
LI XY, WU SY, LEUNG PS. Human fetal bone marrow-derived mesenchymal stem cells promote the proliferation and differentiation of pancreatic progenitor cells and the engraftment function of islet-like cell clusters[J]. Int J Mol Sci, 2019, 20(17): 4083. DOI: 10.3390/ijms20174083.
|
[33] |
REN G, REZAEE M, RAZAVI M, et al. Adipose tissue-derived mesenchymal stem cells rescue the function of islets transplanted in sub-therapeutic numbers via their angiogenic properties[J]. Cell Tissue Res, 2019, 376(3): 353-364. DOI: 10.1007/s00441-019-02997-w.
|
[34] |
BARONE L, PALANO MT, GALLAZZI M, et al. Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support in vivo angiogenesis[J]. Cell Death Discov, 2023, 9(1): 174. DOI: 10.1038/s41420-023-01464-4.
|
[35] |
DUMAN BO, SARIBOYACI AE, KARAOZ E. Bio-engineering of 3-D cell sheets for diabetic rats: Interaction between mesenchymal stem cells and beta cells in functional islet regeneration system[J]. Tissue Cell, 2022, 79: 101919. DOI: 10.1016/j.tice.2022.101919.
|
[36] |
LUO Y, LIANG F, WAN X, et al. Hyaluronic acid facilitates angiogenesis of endothelial colony forming cell combining with mesenchymal stem cell via CD44/ microRNA-139-5p pathway[J]. Front Bioeng Biotechnol, 2022, 10: 794037. DOI: 10.3389/fbioe.2022.794037.
|
[37] |
ELSHEMY MM, ASEM M, ALLEMAILEM KS, et al. Antioxidative capacity of liver- and adipose-derived mesenchymal stem cell-conditioned media and their applicability in treatment of type 2 diabetic rats[J]. Oxid Med Cell Longev, 2021: 8833467. DOI: 10.1155/2021/8833467.
|
[38] |
WANG Y, TIAN M, WANG F, et al. Understanding the immunological mechanisms of mesenchymal stem cells in allogeneic transplantation: from the aspect of major histocompatibility complex class I[J]. Stem Cells Dev, 2019, 28(17): 1141-1150. DOI: 10.1089/scd.2018.0256.
|
[39] |
BOWLES AC, ISHAHAK MM, GLOVER SJ, et al. Evaluating vascularization of heterotopic islet constructs for type 1 diabetes using an in vitro platform[J]. Integr Biol (Camb), 2019, 11(8): 331-341. DOI: 10.1093/intbio/zyz027.
|
[40] |
KHATRI R, MAZUREK S, PETRY SF, et al. Mesenchymal stem cells promote pancreatic β-cell regeneration through downregulation of FoxO1 pathway[J]. Stem Cell Res Ther, 2020, 11(1): 497. DOI: 10.1186/s13287-020-02007-9.
|